SCHEMBL15093801

SCHEMBL15093801

CNS(=O)(=O)NC(=O)c1ccc(Oc2ccc(Cl)c(C(F)(F)F)c2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 9/20 0.67
SCN5A Q14524 1/20 0.54
BRAF P15056 5/20 0.52
RAF1 P04049 5/20 0.52
HDAC1 Q13547 3/20 0.52
HDAC3 O15379 2/20 0.52
HDAC4 P56524 2/20 0.52
HDAC7 Q8WUI4 2/20 0.52
HDAC2 Q92769 2/20 0.52
HDAC10 Q969S8 2/20 0.52
HDAC11 Q96DB2 2/20 0.52
HDAC8 Q9BY41 2/20 0.52
HDAC6 Q9UBN7 2/20 0.52
HDAC9 Q9UKV0 2/20 0.52
HDAC5 Q9UQL6 2/20 0.52
ARAF P10398 2/20 0.52
KDR P35968 3/20 0.47
MEN1 O00255 1/20 0.47
PLK4 O00444 1/20 0.47
CIT O14578 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Diethylamine SCHEMBL17158631 0.94 SCN9A (0.61) SCN9ASCN5ABRAFRAF1HDAC1
SCHEMBL371116 0.88 SCN9A (0.67) SCN9ASCN5ABRAFRAF1HDAC1
SCHEMBL15094332 0.86 SCN9A (0.66) SCN9ASCN5ABRAFRAF1HDAC1
SCHEMBL15094343 0.85 SCN9A (0.68) SCN9ASCN5ABRAFRAF1HDAC1
SCHEMBL16319527 0.85 SCN9A (0.53) SCN9ASCN5ABRAFRAF1HDAC1
SCHEMBL371316 0.82 SCN9A (0.50) SCN9ASCN5ABRAFRAF1HDAC1
Diethylamine SCHEMBL17158644 0.81 SCN9A (0.58) SCN9ASCN5ABRAFRAF1HDAC1
SCHEMBL15543230 0.81 SCN9A (1.00) SCN9ASCN5A
Diethylamine SCHEMBL17158640 0.80 SCN9A (0.61) SCN9ASCN5ABRAFRAF1HDAC1
SCHEMBL364772 0.79 RAF1 (0.53) SCN9ASCN5ABRAFRAF1HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150291514-A1 N-Aminosulfonyl Benzamides PFIZER LIMTED (GB) 2015-10-15 US disclosed
US-20150291514-A1 N-Aminosulfonyl Benzamides PFIZER LIMTED (GB) 2015-10-15 US disclosed
US-20150291514-A1 N-Aminosulfonyl Benzamides PFIZER LIMTED (GB) 2015-10-15 US disclosed
EP-2800740-A1 N-AMINOSULFONYL BENZAMIDES Pfizer Limited (GB) 2014-11-12 EP disclosed
WO-2013102826-A1 N-AMINOSULFONYL BENZAMIDES PFIZER LIMITED (GB) 2013-07-11 WO disclosed
WO-2013102826-A1 N-AMINOSULFONYL BENZAMIDES PFIZER LIMITED (GB) 2013-07-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150291514-A1 N-Aminosulfonyl Benzamides SCN7A, SCN2B, SCN1B SCN9A 14/4885SCN5A 5/4885BRAF 450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.